Literature DB >> 25727288

Approaches for analyzing the roles of mast cells and their proteases in vivo.

Stephen J Galli1, Mindy Tsai2, Thomas Marichal3, Elena Tchougounova4, Laurent L Reber2, Gunnar Pejler5.   

Abstract

The roles of mast cells in health and disease remain incompletely understood. While the evidence that mast cells are critical effector cells in IgE-dependent anaphylaxis and other acute IgE-mediated allergic reactions seems unassailable, studies employing various mice deficient in mast cells or mast cell-associated proteases have yielded divergent conclusions about the roles of mast cells or their proteases in certain other immunological responses. Such "controversial" results call into question the relative utility of various older versus newer approaches to ascertain the roles of mast cells and mast cell proteases in vivo. This review discusses how both older and more recent mouse models have been used to investigate the functions of mast cells and their proteases in health and disease. We particularly focus on settings in which divergent conclusions about the importance of mast cells and their proteases have been supported by studies that employed different models of mast cell or mast cell protease deficiency. We think that two major conclusions can be drawn from such findings: (1) no matter which models of mast cell or mast cell protease deficiency one employs, the conclusions drawn from the experiments always should take into account the potential limitations of the models (particularly abnormalities affecting cell types other than mast cells) and (2) even when analyzing a biological response using a single model of mast cell or mast cell protease deficiency, details of experimental design are critical in efforts to define those conditions under which important contributions of mast cells or their proteases can be identified.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basophils; Cre recombinase; Mouse model; Stem cell factor; c-kit

Mesh:

Substances:

Year:  2015        PMID: 25727288      PMCID: PMC4771191          DOI: 10.1016/bs.ai.2014.11.002

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  319 in total

1.  Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses.

Authors:  E M Erin; B R Leaker; A Zacharasiewicz; L A Higgins; G C Nicholson; M J Boyce; P de Boer; R C Jones; S R Durham; P J Barnes; T T Hansel
Journal:  Clin Exp Allergy       Date:  2006-04       Impact factor: 5.018

2.  Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells.

Authors:  Michelle B Bowie; David G Kent; Michael R Copley; Connie J Eaves
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

Review 3.  Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses.

Authors:  Michele A Grimbaldeston; Martin Metz; Mang Yu; Mindy Tsai; Stephen J Galli
Journal:  Curr Opin Immunol       Date:  2006-10-02       Impact factor: 7.486

4.  Genetic variation determines mast cell functions in experimental asthma.

Authors:  Marc Becker; Sebastian Reuter; Pamela Friedrich; Fatma Doener; Anastasija Michel; Tobias Bopp; Matthias Klein; Edgar Schmitt; Hansjörg Schild; Markus P Radsak; Bernd Echtenacher; Christian Taube; Michael Stassen
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

5.  Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens.

Authors:  Anne Dudeck; Jan Dudeck; Julia Scholten; Anke Petzold; Sangeetha Surianarayanan; Anja Köhler; Katrin Peschke; David Vöhringer; Claudia Waskow; Thomas Krieg; Werner Müller; Ari Waisman; Karin Hartmann; Matthias Gunzer; Axel Roers
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

6.  Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.

Authors:  D Dombrowicz; V Flamand; I Miyajima; J V Ravetch; S J Galli; J P Kinet
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 7.  Anaphylaxis: lessons from mouse models.

Authors:  Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2007-09       Impact factor: 10.793

8.  Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats.

Authors:  N Arizono; T Kasugai; M Yamada; M Okada; M Morimoto; H Tei; G F Newlands; H R Miller; Y Kitamura
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

9.  Mast cells are required for experimental oral allergen-induced diarrhea.

Authors:  Eric B Brandt; Richard T Strait; Dan Hershko; Quan Wang; Emily E Muntel; Troy A Scribner; Nives Zimmermann; Fred D Finkelman; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin.

Authors:  J R Gordon; S J Galli
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

View more
  43 in total

1.  TGF-β1 Suppresses IL-33-Induced Mast Cell Function.

Authors:  Victor S Ndaw; Daniel Abebayehu; Andrew J Spence; Patrick A Paez; E Motunrayo Kolawole; Marcela T Taruselli; Heather L Caslin; Alena P Chumanevich; Anuya Paranjape; Bianca Baker; Brian O Barnstein; Tamara T Haque; Kasalina N Kiwanuka; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2017-06-21       Impact factor: 5.422

2.  Serotonin signalling is crucial in the induction of PUVA-induced systemic suppression of delayed-type hypersensitivity but not local apoptosis or inflammation of the skin.

Authors:  Peter Wolf; Scott N Byrne; Alberto Y Limon-Flores; Gerald Hoefler; Stephen E Ullrich
Journal:  Exp Dermatol       Date:  2016-04-18       Impact factor: 3.960

Review 3.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

Review 4.  Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms.

Authors:  Stephen J Galli; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

5.  Imaging protective mast cells in living mice during severe contact hypersensitivity.

Authors:  Laurent L Reber; Riccardo Sibilano; Philipp Starkl; Axel Roers; Michele A Grimbaldeston; Mindy Tsai; Nicolas Gaudenzio; Stephen J Galli
Journal:  JCI Insight       Date:  2017-05-04

6.  Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice.

Authors:  Nicolas Gaudenzio; Riccardo Sibilano; Philipp Starkl; Mindy Tsai; Stephen J Galli; Laurent L Reber
Journal:  J Vis Exp       Date:  2015-05-27       Impact factor: 1.355

Review 7.  An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses.

Authors:  Melissa A Brown; Maureen A Su
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

8.  Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation.

Authors:  Nicholas J Shubin; Veronika A Glukhova; Morgan Clauson; Phuong Truong; Magnus Abrink; Gunnar Pejler; Nathan J White; Gail H Deutsch; Stephen R Reeves; Tomas Vaisar; Richard G James; Adrian M Piliponsky
Journal:  J Allergy Clin Immunol       Date:  2016-05-13       Impact factor: 10.793

9.  Mast cells and IgE in defense against lethality of venoms: Possible "benefit" of allergy[].

Authors:  Stephen J Galli; Martin Metz; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Allergo J Int       Date:  2020-03-02

Review 10.  Tryptase as a polyfunctional component of mast cells.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Vera Samoilova; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2018-03-12       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.